Literature DB >> 173302

Influence of anti-oestrogens on the specific binding in vitro of (3H)oestradiol by cytosol of rat mammary tumours and human breast carcinomata.

W Powell-Jones, D A Jenner, R W Blamey, P Davies, K Griffiths.   

Abstract

The anti-oestrogenic potential of two nitrogen-mustard-containing compounds, I.C.I. 79792 and I.C.I. 85966, was studied. I.C.I. 85966 usually did not decrease specific binding of [3H]oestradiol by breast-tumour cytoplasmic proteins. I.C.I. 79792 decreased specific [3H]oestradiol binding, but not to the same extent as similar concentrations of I.C.I. 46474, diethylstilboestrol or dibutyldihydrostilboestrol.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 173302      PMCID: PMC1165705          DOI: 10.1042/bj1500071

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

Review 1.  Mechanism of action of the female sex hormones.

Authors:  E V Jensen; E R DeSombre
Journal:  Annu Rev Biochem       Date:  1972       Impact factor: 23.643

2.  Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels.

Authors:  H W Ward
Journal:  Br Med J       Date:  1973-01-06

3.  Stimulation of ribonucleic acid polymerase activity in vitro by prostatic steroid-protein receptor complexes.

Authors:  P Davies; K Griffiths
Journal:  Biochem J       Date:  1973-11       Impact factor: 3.857

4.  The influence of synthetic anti-estrogens on the binding of tritiated estradiol-17beta by cytosols of human uterus and human breast carcinoma.

Authors:  R Hähnel; E Twaddle; T Ratajczak
Journal:  J Steroid Biochem       Date:  1973-11       Impact factor: 4.292

5.  The steroid specificity of the estrogen-receptor of human breast carcinoma.

Authors:  R Hähnel; E Twaddle
Journal:  J Steroid Biochem       Date:  1974-04       Impact factor: 4.292

Review 6.  Estrogen-receptor interaction.

Authors:  E V Jensen; E R DeSombre
Journal:  Science       Date:  1973-10-12       Impact factor: 47.728

7.  Estrogens and antiestrogens.

Authors:  C Geynet; C Millet; H Truong; E E Baulieu
Journal:  Gynecol Invest       Date:  1972

8.  The use of estrogen antagonists in hormone receptor studies.

Authors:  E V Jensen; H I Jacobson; S Smith; P W Jungblut; E R De Sombre
Journal:  Gynecol Invest       Date:  1972

9.  3H-oestradiol uptake in vivo by human uterine endometrium: effect of tamoxifen (I.C.I. 46,474).

Authors:  C B Lunan; B Green
Journal:  Clin Endocrinol (Oxf)       Date:  1974-10       Impact factor: 3.478

Review 10.  Hormone-receptor interaction as a guide to biochemical mechanism.

Authors:  E V Jensen; M Numata; P I Brecher; E R Desombre
Journal:  Biochem Soc Symp       Date:  1971
View more
  3 in total

1.  Tamoxifen in the management of metastatic cancer of the breast.

Authors:  L A Cone; N E Romanoff; N A Helm
Journal:  West J Med       Date:  1979-09

Review 2.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

3.  Research at the Tenovus Institute.

Authors:  K Griffiths
Journal:  J R Coll Physicians Lond       Date:  1976-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.